Nav: Home

Large-scale analysis of protein arginine methylation by mass spectrometry

May 22, 2020

Methylation (namely addition of a methyl group) of arginine amino acid residues of proteins is a post-translational modification (PTM) catalyzed by a family of nine enzymes called Protein Arginine Methyl-Transferases (PRMTs).

PRMTs have been gaining increasing attention in the scientific landscape due their role in several essential physiological processes and implication in various diseases, including cancer and neurological disorders; loss of PRMT1 is lethal at the early developmental stages, while overexpression is frequently observed in different tumor types and correlates with poor patient prognosis, suggesting that inhibition of PRMTs may represent an effective therapeutic approach in oncology. Moreover, PTM levels are deregulated in different tumor types, and both local and global changes in PTM of the DNA-associated proteins - the histones - are linked to Amyotrophic Lateral Sclerosis. Due to the large body of scientific evidence indicating their role in cell pathophysiology, several PRMT inhibitors have been designed and developed as a potential new class of drugs. For instance, a potent, reversible type I PRMT inhibitor has been shown to have anti-tumor effects in human cancer models and some of the molecular candidates have entered clinical trials for solid tumors and lymphomas.

"Although it was first described in 1968," says Dr Tiziana Bonaldi, Group Leader at the European Institute of Oncology, "for almost 30 years, very little was known about the extent of protein arginine methylation, its effect on protein activity, and its biological role. The first PRMT, capable of catalyzing arginine methylation, was discovered in 1996 and, since then, nine proteins exerting the same functions have been discovered. However, inefficient analytical approaches have largely limited a comprehensive understanding of their biological function. Quantitative Mass spectrometry has emerged as the ideal analytical strategy to study the extent of protein arginine-methylation in model systems and identify PRMT targets, thus contributing substantial knowledge in this field."

In their article published in Current Protein & Peptide Science, Dr. Bonaldi and co-workers offer an overview on state-of-the-art arginine methyl-proteomics, describing the innovations that led - from the description by Mathias Mann's group of the first high-quality methyl-proteome in 2004 - to the latest studies that profile protein-methylation events occurring on hundreds of cellular proteins. Throughout this review, the authors describe the implementations both in the biochemical methods and in the computational methods for Mass spectrometry data analysis or the identification of sites of arginine methylation, discussing the pros and cons of the most common strategies employed.

Furthermore, relevant issues related to protein-arginine methylation analysis that are still under development are also discussed, such as the discrimination of symmetric and asymmetric arginine-di-methylation from Mass spectrometry fragmentation spectra. "These two modifications have identical mass, yet they are catalyzed by different PRMTs and have substantially different biological outcomes," explains Bonaldi; "Indeed, even though, for instance, both have a role in regulation of transcription, while asymmetric di-methylation is activating, symmetric di-methylation is repressive. Therefore, being able to distinguish between the two processes is crucial."

Finally, major emphasis is devoted to the heavy methyl SILAC strategy, a variation of the more conventional SILAC (Stable Isotope Labelling with Amino acids in Cell culture). "The heavy methyl SILAC strategy was designed to increase the confidence of in vivo arginine methyl-peptides identification by Mass spectrometry," - continues Bonaldi - "and the use will be facilitated by the recent development of ad hoc algorithms tailored for processing of heavy methyl SILAC datasets, such as MethylQuant and hmSEEKER."

Importantly, the authors conclude that optimization of the currently available analytical approaches and their systematic application will play a key role in the future research on the involvement of protein methylation in biological processes, providing critical insights in the related cellular biology processes and likely offering potential novel targets to be exploited in a clinical context.
-end-
To get the full-text article, please visit the following link: http://www.eurekaselect.com/181344/article

Bentham Science Publishers

Related Methylation Articles:

Large-scale analysis of protein arginine methylation by mass spectrometry
In this research, the researchers offer an overview on state-of-the-art approaches for the high-confidence identification and accurate quantification of protein arginine methylation by high-resolution mass spectrometry methods, which comprise the development of both biochemical and bioinformatics methods.
Oncotarget: DNA methylation of MMPs and TIMPs in atherothrombosis process in carotid plaques
Oncotarget Volume 11, Issue 10 reported that the statistically associated Cp G sites were analyzed in blood samples from two separate atherothrombotic stroke cohorts, ischemic stroke-cohort 1: 37 atherothrombotic patients and 6 controls, ischemic stroke-cohort 2: 80 atherothrombotic patients and 184 controls.
Stressed corals set up progeny for a better life
First evidence that animal DNA methylation patterns can be passed to the next generation.
RNA modification -- Methylation and mopping up
Ludwig-Maximilian-Universitaet (LMU) in Munich researchers have discovered a novel type of chemical modification in bacterial RNAs.
Structural and biochemical studies clarify the methylation mechanism of anticodon in tRNA
Groups in Ehime University, Japan and the High Energy Accelerator Research Organization (KEK), Japan have solved the crystal structure of the eukaryotic Trm7-TRm734 complex, which methylates the ribose at the first position of anticodon in tRNA.
First glimpse at what ancient Denisovans may have looked like, using DNA methylation data
Exactly what our ancient Denisovan relatives might have looked like had been anyone's guess for a simple reason: the entire collection of Denisovan remains includes a pinky bone, three teeth, and a lower jaw.
Methylation of microRNA may be a new powerful biomarker for cancer
Researchers from Osaka University found that levels of methylated microRNA were significantly higher in tissue and serum from cancer patients compared with that from normal controls.
DNA methylation-based estimator of telomere length
Leukocyte DNAm TL is applicable across the entire age spectrum and is more strongly associated with age than measured leukocyte TL.
Scientists uncover mystery of DNA methylation
To a large extent, DNA methylation, which regulates vital cell functions, is still a big mystery to the scientific world.
Study finds fish preserve DNA 'memories' far better than humans
We are all familiar with the common myth that fish have poor memory, but it turns that their DNA has the capacity to hold much more memory than that of humans.
More Methylation News and Methylation Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Clint Smith
The killing of George Floyd by a police officer has sparked massive protests nationwide. This hour, writer and scholar Clint Smith reflects on this moment, through conversation, letters, and poetry.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Nina
Producer Tracie Hunte stumbled into a duet between Nina Simone and the sounds of protest outside her apartment. Then she discovered a performance by Nina on April 7, 1968 - three days after the assassination of Dr. Martin Luther King Jr. Tracie talks about what Nina's music, born during another time when our country was facing questions that seemed to have no answer, meant then and why it still resonates today.  Listen to Nina's brother, Samuel Waymon, talk about that April 7th concert here.